DNA transposon mechanisms and pathways of genotoxicity.
DNA transposon mechanisms and pathways of genotoxicity.
复制标题
DNA转座子基因毒性机制和途径。
DOI:
10.1016/j.ymthe.2023.01.023
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Bushman,FredericD
中科院分区:
文献类型:
--
作者:
Bushman,FredericD
Recently two lymphomas were reported in a chimeric antigen receptor (CAR) T cancer therapy trial (the CARTELL study) 1, 2 in which the piggyBac DNA transposon was used to deliver an engineered receptor gene to human T cells. The transformed cells were found to contain multiple integrated transposon DNA copies (4–24 per cell) and harbor multiple rearrangements in cellular chromosomal DNA. A variety of factors may have contributed to transformation, including aspects of the vector design and cell processing. 1, 2 In evaluating possible mechanisms of transformation, it may be useful to consider the properties of transposition that differ from the more familiar retroviral integration and ask whether these could have influenced development of the two lymphomas. For example, transposon DNA integrated in a host chromosome can be a substrate for further rounds of excision and transposition, where each excision event generates a DNA double-strand break at the empty transposon-donor site. Transposases can also cleave genomic DNA directly at chromosomal sequences that, by chance, resemble transposase-binding sites. These mechanisms are described more fully below, and additional experiments are described that could help clarify possible pathways of genotoxicity and potentially mitigate risks.Use of DNA transposons 3 for gene addition has the advantage over retroviral delivery of bypassing the step of vector particle generation and so may be simpler and less expensive to use. However, recently two cases of lymphoma were found in a CAR T trial to treat B cell malignancies following piggybac delivery, 1, 2 and the transformed cells contained multiple integrated transposons and chromosomal rearrangements. The authors suggested that insertional mutagenesis was not a factor in the two cases, though transformed cells from both adverse events harbored integra-
登录
查看更多内容
影响因子:
3.9
作者:
Lusine Nazaryan;B. Bertelsen;M. Bak;L. Jønson;N. Tommerup;Dustin C. Hancks;Z. Tümer
通讯作者:
Z. Tümer
影响因子:
5.3
作者:
Li, Meng Amy;Pettitt, Stephen J.;Bradley, Allan
通讯作者:
Bradley, Allan
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
Ikeda;T.;Shibata;J.;Yoshimura;K.;Koito;A.;Matsushita;S.
通讯作者:
S.
影响因子:
5.6
作者:
Helou L;Beauclair L;Dardente H;Piégu B;Tsakou-Ngouafo L;Lecomte T;Kentsis A;Pontarotti P;Bigot Y
通讯作者:
Bigot Y